The largest database of trusted experimental protocols

Sybr green premix

Manufactured by Vazyme
Sourced in China, United States

SYBR-Green Premix is a ready-to-use solution for real-time quantitative PCR (qPCR) analysis. It contains SYBR Green I dye, DNA polymerase, dNTPs, and necessary buffers and reagents. The SYBR-Green Premix is designed to provide a simple and efficient method for quantifying target DNA sequences in real-time PCR experiments.

Automatically generated - may contain errors

25 protocols using sybr green premix

1

Quantitative RT-PCR Analysis of RNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cellular RNA was isolated using the TRIzol reagent (Thermo) and then subjected to reverse transcription using the RNA-to-cDNA kit (Takara). To quantify RNA expression, qRT-PCR analysis with SYBR Green Premix (Vazyme) was performed using the QuantStudio 6 Flex system (ABI) with ACTB serving as an internal control. The primer sequences for qRT-PCR are specified in Supplementary Table 3.
+ Open protocol
+ Expand
2

RNA Isolation and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from the tissues homogenates and HT-29 cells by using Trizol reagent (Takara, Otsu, Japan). According to the manufacturer’s protocol, cDNA synthesis was carried out by commercial cDNA synthesis kits (Vazyme Biotech, R223-01), and subjected to quantitative PCR using SYBR Green Premix (Vazyme Biotech, Q141-02/03) with a StepOne Real-Time PCR System (Applied Biosystems). Sequences of the primers are listed in Table S2.
+ Open protocol
+ Expand
3

Quantitative Analysis of mRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
TRIzol reagent (Vazyme, Nanjing, China) was used to extract total RNA from the tissue. PrimeScript RT-polymerase (Vazyme) was used for reverse transcription to obtain cDNAs corresponding to the target mRNAs. qRT-PCR was performed using SYBR-Green Premix (Vazyme) and specific PCR primers (Sangon Biotech Co., Ltd, Shanghai, China). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control. Primer sequences are shown in Supplementary Table S2. The 2−ΔΔCt method was used to calculate the relative fold-changes in mRNA expression.
+ Open protocol
+ Expand
4

Differential Expression of E2Fs in Endometrial Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 27 EC tissues and 20 normal endometrial tissues were obtained from patients who underwent a hysterectomy or endometrial curettage for endometrial-irrelevant diseases in Shengjing Hospital of China Medical University, China, from 2017 to 2019. All patients provided informed consent, and this study was approved by the Ethics Committee of Shengjing Hospital of China Medical University. Histological diagnosis and tumor grade were assessed by three experienced pathologists in accordance with the International Federation of Gynecology and Obstetrics (FIGO 2009). None of the patients received any local or systemic treatment preoperatively.
Total RNA of EC tissues and normal endometrial tissues were extracted with TRIzol reagent (Vazyme, Nanjing, China). The synthesis of cDNAs corresponding to the mRNAs of interest depended on PrimeScript RT-polymerase (Vazyme). SYBR-Green Premix (Vazyme) with specific PCR primers (Sangon Biotech Co., Ltd., Shanghai, China). Glyceraldehyde-3-phosphate dehydrogenase was used as an internal control. The 2-ΔΔCt method was used to calculate fold-changes. Primer sequences are shown in Supplementary Table 1. The difference of the expression of E2Fs in tumor tissues and normal tissues were evaluated with Student’s t-test in GraphPad Prism7 software (GraphPad, Inc., La Jolla, CA, USA).
+ Open protocol
+ Expand
5

BCL2 Expression in Breast Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained 52 breast cancer tissues and normal breast tissues from patients who underwent a breast cancer removal in Union Hospital of Tongji Medical College. The studies involving human participants were reviewed and approved by the Ethics Committee of Union Hospital of Tongji Medical College. The patients/participants provided their written informed consent to participate in this study. Histological diagnosis and tumor grade were assessed by three experienced pathologists in accordance with the 2010 American Joint Committee on Cancer staging system.
The total RNA of breast cancer tissues and normal tissues was extracted with the TRIzol reagent (Vazyme, Nanjing, China). The synthesis of cDNAs corresponding to the mRNAs of interest depended on PrimeScript RT-polymerase (Vazyme) and SYBR-Green Premix (Vazyme) with specific PCR primers (Sangon Biotech Co., Ltd, Shanghai, China). The specific primers used were as follows: GAPDH-F: GGG​AAG​GTG​AAG​GTC​GGA​GT; GAPDH-R: GGG​GTC​ATT​GAT​GGC​AAC​A; BCL2-F: ACT​GGC​TCT​GTC​TGA​GTA​AG; BCL2-R: CCT​GAT​GCT​CTG​GGT​AAC. The fold-changes were calculated with the 2−ΔΔCt method. The difference in BCL2 expression and the prognosis of BCL2 in breast cancer were evaluated with Student’s t-test and the Kaplan–Meier analysis in GraphPad Prism 7 software (GraphPad, Inc., La Jolla, CA, United States).
+ Open protocol
+ Expand
6

Quantifying Gene Expression via RT-qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol reagent (Vazyme, Nanjing, China). Subsequently, cDNAs were synthesized using Prime Script RT-polymerase (Vazyme). SYBR Green Premix (Vazyme) with specific PCR primers (Sangon Biotech, Shanghai, China) were used to detect the expression level of corresponding gene RNA. The primer sequences are provided in Supplementary Table 2. The fold-changes were calculated using the 2−ΔΔCT method.
+ Open protocol
+ Expand
7

PIK3CB Expression in Kidney Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
After obtained informed consent from patients of Affiliated hospital of Jingchu University of Technology, we obtained KIRC tissues and pair-normal renal tissues (n = 46) from these patients. Our study was approved by the ethics committee of affiliated hospital of Jingchu University of Technology. None of patient received local or systemic treatment preoperatively. TRIzol reagent (Vazyme, Nanjing, China) was used to isolate total RNA. The synthesis of cDNAs corresponding to the mRNAs of interest was conducted with PrimeScript RT-polymerase (Vazyme). SYBR-Green Premix (Vazyme) and specific PCR primers (Sangon, China). The primers used in this study for qRT-PCR analysis obtained from BioSune Biotechnology (Shanghai, China) and listed as follows: PIK3CB: Forward, 5′-TATTTGGACTTTGCGACAAGACT-3′ and Reverse, 5′-TCGAACGTACTGGTCTGGATAG-3′; β-actin: Forward, 5′-GCACCGCAAATGCTTCTA-3′ and Reverse, 5′-GGTCTTTACGGATGTCAACG-3′. The 2−ΔΔCt method was used to calculate fold-changes. The difference of the expression of PIK3CB and the prognosis of PIK3CB in KIRC were explored with Student t test and Kaplan-Meier analysis, respectively.
+ Open protocol
+ Expand
8

Quantitative RT-PCR for Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from tissues using TRIzol reagent (Vazyme, Nanjing, China). PrimeScript RT-polymerase (Vazyme) was used to reverse-transcribe cDNAs corresponding to the mRNAs of interest. qRT-PCR was performed using SYBR-Green Premix (Vazyme) with specific PCR primers (Sangon Biotech Co., Ltd, Shanghai, China). Glyceraldehyde-3-phosphate dehydrogenase was used as an internal control. The 2−ΔΔCt method was used to calculate fold-changes. Primer sequences are listed in Additional file 1: Table S1.
+ Open protocol
+ Expand
9

Gene Expression Analysis via qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from cell samples utilizing RNA-easy isolation reagent (Vazyme Biotech), which was then reversed into cDNA by PrimeScript Mix reagent (Takara). SYBR Green Premix (Vazyme Biotech) was prepared for use in the PCR system. The value of individual genes was finally standardized to the GAPDH expression level. The primer sequences for indicated genes are displayed in Supplementary Table S1.
+ Open protocol
+ Expand
10

RNA Extraction and qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cell RNA was extracted by RNA isolation reagent (Takara), then reversed into cDNA by PrimeScript Mix reagent (Takara). SYBR Green Premix (Vazyme biotech) was utilized for PCR reaction system. The value of individual genes was standardized to GAPDH expression level. Supplementary Table S2 displays primer sequences of all genes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!